In clinical studies with infliximab in which 5780 patients were treated, representing 5494 patient years, 5 cases of lymphomas and 26 non-lymphoma malignancies were detected as compared with no lymphomas and 1 non-lymphoma malignancy in 1600 placebo-treated patients representing 941 patient years.
Infliksimabi kliinilistes uuringutes, milles sai ravi 5780 patsienti ja mis kokkuvõtvalt esindab 5494 patsiendiaastat, on esinenud 5 lümfoomi ja 26 mitte- lümfoomset pahaloomulist kasvajat võrreldes lümfoomide mitte- esinemisega ja 1 mitte - lümfoomse pahaloomulise kasvaja esinemisega 1600 platseebot saanud patsiendi seas, mis